| |
| |
|
| Insider
Information: |
Mathews Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
290,010 |
|
|
Indirect Shares
|
6,875 |
|
|
| Direct
Value |
$199,160 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
296,885 |
|
|
| Total
Value |
$199,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2012-03-06 |
270,094 |
2012-03-06 |
6,875 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
Director |
2016-03-09 |
19,916 |
2012-11-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,485 |
19,916 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2015-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,715 |
16,431 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2014-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,858 |
10,716 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2012-12-19 |
4 |
B |
$4.98 |
$24,900 |
D/D |
5,000 |
7,858 |
2.39 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2012-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,858 |
2,858 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2012-03-06 |
4 |
B |
$2.69 |
$13,473 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2012-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
270,094 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
240,094 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2010-02-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
40,000 |
210,094 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2010-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
40,000 |
211,969 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
171,969 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
I/I |
56,911 |
111,969 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
53,183 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
8,935 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
